Proposed Data Collection Submitted for Public Comment and Recommendations, 40050-40051 [2021-15795]
Download as PDF
<![CDATA[
40050
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–15792 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0800; Docket No. CDC–2021–
0072]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns.
CDC is requesting a Revision to this
Generic Clearance to include an
additional cancer-related
communications campaign, expand the
modes of data collection to include
online focus groups and in-depth
interviews (in-person, phone, and
online), and to focus on respondents
from the general public.
DATES: CDC must receive written
comments on or before September 24,
2021.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0072 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
jbell on DSKJLSW7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communications Campaigns—
(OMB Control No. 0920–0800, Exp. 10/
31/2021)—Revision—National Center
for Chronic Disease Prevention and
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The mission of the CDC’s Division of
Cancer Prevention and Control (DCPC)
is to reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, and improved quality of life
for cancer survivors. Toward this end,
the DCPC supports the scientific
development and implementation of
various health communication
campaigns with an emphasis on specific
cancer burdens.
This process requires testing of
messages, concepts, and materials prior
to their final development and
dissemination, as described in the
second step of the health
communication process. The health
communication process is a scientific
model developed by the U.S.
Department of Health and Human
Services’ National Cancer Institute to
guide sound campaign development.
The communication literature supports
various data collection methods to
conduct credible formative, concept,
message, and materials testing. This
process ensures that the public clearly
understands cancer-specific information
and concepts, are motivated to take the
desired action, and do not react
negatively to the messages. CDC is
currently approved to collect
information needed to plan and tailor
cancer communication campaigns (OMB
Control No. 0920–0800, Exp. 10/31/
2021), and seeks OMB approval to
revise the existing generic clearance to
include another cancer-related
communications campaign, expand the
modes of data collection to include
online focus groups and in-depth
interviews (in-person, phone, and
online), and to focus on respondents
from the general public.
Information collection will involve
discussions to assess numerous
qualitative dimensions of cancer
prevention and control messages
including, but not limited to, cancer
knowledge, attitudes, beliefs, behavioral
intentions, information needs and
sources, and compliance with cancer
screening as recommended by the
United States Preventive Services Task
Force. Insights gained from these
discussions will assist in the
development and/or refinement of
future campaign messages and
materials. Communication campaigns
and messages will vary according to the
type of cancer and the qualitative
dimensions of the message described
above. A separate information collection
E:\FR\FM\26JYN1.SGM
26JYN1
40051
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
request will be submitted to OMB for
approval of each discussion activity.
The request will describe the purpose of
the activity and include the customized
information collection instruments.
OMB approval is requested for three
years. There is no change in burden
hours or respondents. Participation is
voluntary and there are no costs to
respondents except their time. CDC
requests approval for an estimated 1,680
annual burden hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Total
burden
(in hours)
Form name
General Public ..................................
General Public ..................................
Screening Form ................................
Discussion Guide .............................
1600
800
1
1
3/60
2
80
1,600
Total ...........................................
...........................................................
........................
........................
........................
1,680
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–15795 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–15800 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee (MSHRAC);
Cancellation of Meeting
[30Day–21–0556]
Notice is hereby given of a change in
the meeting of the Mine Safety and
Health Research Advisory Committee
(MSHRAC); June 21, 2021, 10:00 a.m.–
2:30 p.m., EDT, in the original FRN.
The meeting was published in the
Federal Register on April 23, 2021,
Volume 86, Number 77, page 21739.
This meeting is being canceled in its
entirety.
FOR FURTHER INFORMATION CONTACT:
jbell on DSKJLSW7X2PROD with NOTICES
Average
burden per
response
(in hours)
Type of respondents
George W. Luxbacher, Designated
Federal Officer, MSHRAC, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, 2400 Century Parkway NE,
Atlanta, GA 30345; Telephone: (404)
498–2808; email: gluxbacher@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assisted
Reproductive Technology (ART)
Program Reporting System’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 12, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Assisted Reproductive Technology
(ART) Program Reporting System (OMB
Control No. 0920–0556, Exp. 8/31/
2021)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40050-40051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15795]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0800; Docket No. CDC-2021-0072]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Focus Group Testing to
Effectively Plan and Tailor Cancer Prevention and Control Communication
Campaigns. CDC is requesting a Revision to this Generic Clearance to
include an additional cancer-related communications campaign, expand
the modes of data collection to include online focus groups and in-
depth interviews (in-person, phone, and online), and to focus on
respondents from the general public.
DATES: CDC must receive written comments on or before September 24,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0072 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Focus Group Testing to Effectively Plan and Tailor Cancer
Prevention and Control Communications Campaigns--(OMB Control No. 0920-
0800, Exp. 10/31/2021)--Revision--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The mission of the CDC's Division of Cancer Prevention and Control
(DCPC) is to reduce the burden of cancer in the United States through
cancer prevention, reduction of risk, early detection, and improved
quality of life for cancer survivors. Toward this end, the DCPC
supports the scientific development and implementation of various
health communication campaigns with an emphasis on specific cancer
burdens.
This process requires testing of messages, concepts, and materials
prior to their final development and dissemination, as described in the
second step of the health communication process. The health
communication process is a scientific model developed by the U.S.
Department of Health and Human Services' National Cancer Institute to
guide sound campaign development. The communication literature supports
various data collection methods to conduct credible formative, concept,
message, and materials testing. This process ensures that the public
clearly understands cancer-specific information and concepts, are
motivated to take the desired action, and do not react negatively to
the messages. CDC is currently approved to collect information needed
to plan and tailor cancer communication campaigns (OMB Control No.
0920-0800, Exp. 10/31/2021), and seeks OMB approval to revise the
existing generic clearance to include another cancer-related
communications campaign, expand the modes of data collection to include
online focus groups and in-depth interviews (in-person, phone, and
online), and to focus on respondents from the general public.
Information collection will involve discussions to assess numerous
qualitative dimensions of cancer prevention and control messages
including, but not limited to, cancer knowledge, attitudes, beliefs,
behavioral intentions, information needs and sources, and compliance
with cancer screening as recommended by the United States Preventive
Services Task Force. Insights gained from these discussions will assist
in the development and/or refinement of future campaign messages and
materials. Communication campaigns and messages will vary according to
the type of cancer and the qualitative dimensions of the message
described above. A separate information collection
[[Page 40051]]
request will be submitted to OMB for approval of each discussion
activity. The request will describe the purpose of the activity and
include the customized information collection instruments.
OMB approval is requested for three years. There is no change in
burden hours or respondents. Participation is voluntary and there are
no costs to respondents except their time. CDC requests approval for an
estimated 1,680 annual burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
General Public................ Screening Form.. 1600 1 3/60 80
General Public................ Discussion Guide 800 1 2 1,600
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,680
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15795 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P
